Abstract
ObjectivesTo evaluate the efficacy and safety of different doses and regimens of filgotinib, an oral Janus kinase 1 inhibitor, as add-on treatment to methotrexate (MTX) in patients with active rheumatoid...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have